Mr Mark Chatfield
Mr

Mark Chatfield

Email: 
Phone: 
+61 7 334 65042

Background

A/Prof Mark D. Chatfield is a highly experienced statistician in the UQ Clinical Trials Centre and collaborates with researchers across the Faculty of Health, Medicine and Behavioural Sciences.

In collaboration with health and medical researchers, he has published >200 times in academic journals. He has been an investigator on 30 NHMRC/MRFF funded (>$57M) studies (mostly clinical trials). He has >20 years of experience as a biostatistician in Australia (Brisbane, Darwin, Sydney) and the UK (Cambridge, 2002-2009). He has co-supervised 8 PhD students to completion.

He plays an active role in the Australian Clinical Trials Alliance Statistics in Trials Interest Group.

Stata users around the world enjoy using his table1_mc and blandaltman commands.

He is an Honorary Fellow (Associate Professor) with Menzies School of Health Research.

Availability

Mr Mark Chatfield is:
Not available for supervision

Fields of research

Biomedical and Clinical Sciences Biostatistics Health Sciences Mathematical Sciences Statistics

Qualifications

  • Bachelor of Arts, University of Oxford
  • Masters (Coursework), University of Southampton
  • Masters (Coursework), University of Oxford

Research interests

  • Clinical trials

    Mark has been involved with a plethora of trials of various designs in a broad range of fields. He makes significant contributions to funding applications, trial design, analysis, presentation and interpretation. To date, he has published on 39 randomised trials (protocol and/or results paper). He is involved with methodological research into cluster randomised trials as well as sample size calculations.

  • Meta-analysis

    Mark has been involved with a variety of meta-analyses. He has found a novel way to interpret the heterogeneity parameter, tau, in random-effects meta-analysis of ratios. That said, he advocates for the reporting of tau, or exp(tau) for ratios, rather than tau^2 as it is most easily understood.

Search Professor Mark Chatfield’s works on UQ eSpace

304 works between 2004 and 2026
All (304) Journal Article (223) Conference Publication (80) Book Chapter (1)

241 - 260 of 304 works

2013

Journal Article

A Single Dose of Azithromycin Does Not Improve Clinical Outcomes of Children Hospitalised with Bronchiolitis: A Randomised, Placebo-Controlled Trial

McCallum G.B., Morris P.S., Chatfield M.D., Maclennan C., White A.V., Sloots T.P., Mackay I.M. and Chang A.B. (2013). A Single Dose of Azithromycin Does Not Improve Clinical Outcomes of Children Hospitalised with Bronchiolitis: A Randomised, Placebo-Controlled Trial. PLoS ONE, 8 (9) e74316, 1-9. doi: 10.1371/journal.pone.0074316

A Single Dose of Azithromycin Does Not Improve Clinical Outcomes of Children Hospitalised with Bronchiolitis: A Randomised, Placebo-Controlled Trial

2013

Journal Article

Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment

Ralph, Anna P., Yeo, Tsin W., Salome, Cheryl M., Waramori, Govert, Pontororing, Gysje J., Kenangalem, Enny, Sandjaja,, Tjitra, Emiliana, Lumb, Richard, Maguire, Graeme P., Price, Ric N., Chatfield, Mark D., Kelly, Paul M. and Anstey, Nicholas M. (2013). Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment. Journal of Infectious Diseases, 208 (4), 616-626. doi: 10.1093/infdis/jit248

Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment

2013

Journal Article

L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial

Ralph, Anna P., Waramori, Govert, Pontororing, Gysje J., Kenangalem, Enny, Wiguna, Andri, Tjitra, Emiliana, Sandjaja,, Lolong, Dina B., Yeo, Tsin W., Chatfield, Mark D., Soemanto, Retno K., Bastian, Ivan, Lumb, Richard, Maguire, Graeme P., Eisman, John, Price, Ric N., Morris, Peter S., Kelly, Paul M. and Anstey, Nicholas M. (2013). L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. Plos One, 8 (8) e70032, e70032. doi: 10.1371/journal.pone.0070032

L-arginine and Vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial

2013

Journal Article

Stores Healthy Options Project in Remote Indigenous Communities (SHOP@RIC): a protocol of a randomised trial promoting healthy food and beverage purchases through price discounts and in-store nutrition education

Brimblecombe, Julie, Ferguson, Megan, Liberato, Selma C., Ball, Kylie, Moodie, Marjory L., Magnus, Anne, Miles, Edward, Leach, Amanda J., Chatfield, Mark D., Mhurchu, Cliona Ni, O'Dea, Kerin and Bailie, Ross S. (2013). Stores Healthy Options Project in Remote Indigenous Communities (SHOP@RIC): a protocol of a randomised trial promoting healthy food and beverage purchases through price discounts and in-store nutrition education. BMC Public Health, 13 (1) 744. doi: 10.1186/1471-2458-13-744

Stores Healthy Options Project in Remote Indigenous Communities (SHOP@RIC): a protocol of a randomised trial promoting healthy food and beverage purchases through price discounts and in-store nutrition education

2013

Conference Publication

The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)

Mahon, Kate, Chatfield, Mark, Breit, Samuel, Brown, David, Molloy, Mark, Marx, Gavin, Pavlakis, Nick, Boyer, Michael, Stockler, Martin and Horvath, Lisa (2013). The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC). HOBOKEN: WILEY-BLACKWELL.

The role of macrophages in Docetaxel (DTX) resistance in castrate resistant prostate cancer (CRPC)

2013

Journal Article

Longitudinal Nasopharyngeal Carriage and Antibiotic Resistance of Respiratory Bacteria in Indigenous Australian and Alaska Native Children with Bronchiectasis

Hare, Kim M., Singleton, Rosalyn J., Grimwood, Keith, Valery, Patricia C., Cheng, Allen C., Morris, Peter S., Leach, Amanda J., Smith-Vaughan, Heidi C., Chatfield, Mark, Redding, Greg, Reasonover, Alisa L., McCallum, Gabrielle B., Chikoyak, Lori, McDonald, Malcolm I., Brown, Ngiare, Torzillo, Paul J. and Chang, Anne B. (2013). Longitudinal Nasopharyngeal Carriage and Antibiotic Resistance of Respiratory Bacteria in Indigenous Australian and Alaska Native Children with Bronchiectasis. Plos One, 8 (8) e70478, e70478.1-e70478.8. doi: 10.1371/journal.pone.0070478

Longitudinal Nasopharyngeal Carriage and Antibiotic Resistance of Respiratory Bacteria in Indigenous Australian and Alaska Native Children with Bronchiectasis

2013

Journal Article

Severity scoring systems: Are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?

Mccallum, G.B., Morris, P.S., Wilson, C.C., Versteegh, L.A., Ward, L.M., Chatfield, M.D. and Chang, A.B. (2013). Severity scoring systems: Are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?. Pediatric Pulmonology, 48 (8), 797-803. doi: 10.1002/ppul.22627

Severity scoring systems: Are they internally valid, reliable and predictive of oxygen use in children with acute bronchiolitis?

2013

Journal Article

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer

Grimison, Peter, Houghton, Baerin, Chatfield, Mark, Toner, Guy C., Davis, Ian D., Martin, Jarad, Hovey, Elizabeth and Stockler, Martin R. (2013). Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer. BJU International, 112 (2), E35-E43. doi: 10.1111/bju.12221

Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer

2013

Journal Article

Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer

Spina, R., Chu, S. Y. Y., Chatfield, M., Chen, J., Tin, M. M. and Boyer, M. (2013). Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer. Internal Medicine Journal, 43 (7), 790-797. doi: 10.1111/imj.12138

Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer

2013

Journal Article

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units

Fox, Peter N., Chatfield, Mark D., Beith, Jane M., Allison, Stuart, Della-Fiorentina, Stephen, Fisher, Dean, Turley, Kim and Grimison, Peter S. (2013). Factors delaying chemotherapy for breast cancer in four urban and rural oncology units. ANZ Journal of Surgery, 83 (7-8), 533-538. doi: 10.1111/j.1445-2197.2012.06254.x

Factors delaying chemotherapy for breast cancer in four urban and rural oncology units

2013

Journal Article

Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma

Hong, Angela M., Martin, Andrew, Chatfield, Mark, Jones, Deanna, Zhang, Mei, Armstrong, Bruce, Lee, C. Soon, Harnett, Gerald, Milross, Christopher, Clark, Jonathan, Elliott, Michael, Smee, Robert, Corry, June, Liu, Chen, Porceddu, Sandro, Rees, Guy and Rose, Barbara (2013). Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. International Journal of Cancer, 132 (12), 2748-2754. doi: 10.1002/ijc.27956

Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma

2013

Journal Article

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy

Olver, I. N., Grimison, P., Chatfield, M., Stockler, M. R., Toner, G. C., Gebski, V., Harrup, R., Underhill, C., Kichenadasse, G., Singhal, N., Davis, I. D., Boland, A., McDonald, A. and Thomson, D. (2013). Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy. Supportive Care in Cancer, 21 (6), 1561-1568. doi: 10.1007/s00520-012-1696-0

Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy

2013

Journal Article

Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia

Bowen, Asha C., Tong, Steven Y. C., Chatfield, Mark D., Andrews, Ross M. and Carapetis, Jonathan R. (2013). Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 107 (6), 384-389. doi: 10.1093/trstmh/trt032

Comparison of three methods for the recovery of skin pathogens from impetigo swabs collected in a remote community of Northern Territory, Australia

2013

Conference Publication

The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)

Horvath, Lisa, Chatfield, Mark D., Lee-Ng, Michelle, Lin, Hui-Ming, Castillo, Lesley, Breit, Samuel N., Brown, David A., Molloy, Mark P., Marx, Gavin M., Pavlakis, Nick, Boyer, Michael J., Stockier, Martin R., Wykes, Richard, Henshall, Susan M. and Mahon, Kate Lynette (2013). The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC). 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, May 31-Jun 04, 2013. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

The role of macrophages in docetaxel (DTX) resistance in castrate-resistant prostate cancer (CRPC)

2013

Journal Article

Health-related quality of life and inflammatory markers in malignant pleural mesothelioma

Kao, Steven C., Vardy, Janette, Harvie, Rozelle, Chatfield, Mark, van Zandwijk, Nico, Clarke, Stephen and Pavlakis, Nick (2013). Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer, 21 (3), 697-705. doi: 10.1007/s00520-012-1569-6

Health-related quality of life and inflammatory markers in malignant pleural mesothelioma

2013

Journal Article

Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease

Powell, Jonathan J., Cook, William B., Chatfield, Mark, Hutchinson, Carol, Pereira, Dora I. A. and Lomer, Miranda C. E. (2013). Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease. Nutrition & Metabolism, 10 (1) 18. doi: 10.1186/1743-7075-10-18

Iron status is inversely associated with dietary iron intakes in patients with inactive or mildly active inflammatory bowel disease

2013

Journal Article

Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease

Powell, Jonathan J., Cook, William B., Hutchinson, Carol, Tolkien, Zoe, Chatfield, Mark, Pereira, Dora I. A. and Lomer, Miranda C. E. (2013). Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease. Nutrition & Metabolism, 10 (1) 9. doi: 10.1186/1743-7075-10-9

Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease

2013

Journal Article

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board

Kao, Steven C., Vardy, Janette, Chatfield, Mark, Corte, Peter, Pavlakis, Nick, Clarke, Christopher, van Zandwijk, Nico and Clarke, Stephen (2013). Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board. Clinical Lung Cancer, 14 (1), 70-77. doi: 10.1016/j.cllc.2012.03.011

Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales dust diseases board

2013

Conference Publication

A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial

Mccallum, G., Morris, P. S., Chatfield, M. D., Maclennan, C., White, A., Versteegh, L., Wilson, C., Jacobsen, N. and Chang, A. B. (2013). A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial. Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12046

A single dose of azithromcyin did not improve clinical outcomes in children ≤ 18 months hospitalized with acute bronchiolitis: a double-blind, placebo-controlled randomized trial

2013

Journal Article

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer

Hong, A. M., Martin, A., Armstrong, B. K., Lee, C. S., Jones, D., Chatfield, M. D., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Smee, R., Corry, J., Liu, C., Porceddu, S., Vaska, K., Veness, M., Morgan, G., Fogarty, G., Veivers, D., Rees, G. and Rose, B. (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24 (1) mds205, 215-219. doi: 10.1093/annonc/mds205

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer

Current funding

  • 2026 - 2028
    Matching multidisciplinary management strategies to people with chronic musculoskeletal pain: the MATCH pilot and feasibility randomised clinical trial
    NHMRC MRFF Novel treatments and management strategies for chronic pain
    Open grant
  • 2026 - 2028
    Vibrotexture Insole Technology for Balance Rehabilitation in People with Multiple Sclerosis
    Multiple Sclerosis Research Australia
    Open grant
  • 2025 - 2028
    Improving Food Allergy Outcomes in Adolescents
    NHMRC Clinical Trials and Cohort Studies Grants
    Open grant
  • 2024 - 2028
    The clinical and cost effectiveness of the Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors (The FISS-AUSTRALIA trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2024 - 2027
    Losing touch: Exploring the neurophysiological effects of bionic sensory insole technology for balance rehabilitation
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    Co-creating virtual environments with consumers to enhance self-awareness and preparedness for home after brain injury
    NHMRC MRFF PPHR - Consumer Led Research
    Open grant
  • 2023 - 2028
    The clinical and cost-effectiveness of lumbar fusion surgery for patients with persistent, severe low back pain: FusiOn veRsus bEst coNServative Care (the FORENSIC trial)
    NHMRC-National Institute for Health Research (NIHR) Collaborative Research Grants
    Open grant
  • 2023 - 2028
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2023 - 2027
    Pharmacogenomics for better treatment of fungal infections in cancer
    MRFF Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists
    Open grant
  • 2022 - 2028
    ACTIVE KNEECAPs! tArgeted effeCTIVE treatments for adolescent KNEECAP pain
    NHMRC MRFF EPCDR - Chronic Musculoskeletal Conditions in Children and Adolescents
    Open grant
  • 2022 - 2028
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2026
    Technology Assisted and Remotely Delivered Anxiety Psychotherapy Intervention for People living with Dementia and Their Care Partners (Tech-CBT)
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2019 - 2026
    Preventing recurrent respiratory-related hospitalisations in young Indigenous children through regular azithromycin: a multi-centre.... (NHMRC Project Grant led by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant

Past funding

  • 2019 - 2024
    Improving outcomes of children and young adults with primary ciliary dyskinesia (PCD):... (MRFF RCRDUN administered by Menzies School of Health Research)
    Menzies School of Health Research
    Open grant
  • 2019
    Cluster randomised trial of Staphylococcus aureus decolonisation to prevent surgical site infections
    HCF Research Foundation
    Open grant

Availability

Mr Mark Chatfield is:
Not available for supervision

Supervision history

Current supervision

  • Doctor Philosophy

    Novel trial design in evaluation of antibiotics.

    Associate Advisor

    Other advisors: Dr Patrick Harris

Completed supervision

Enquiries

For media enquiries about Mr Mark Chatfield's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au